Kathleen Coelingh

1.6k total citations
34 papers, 1.3k citations indexed

About

Kathleen Coelingh is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Kathleen Coelingh has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 14 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Kathleen Coelingh's work include Respiratory viral infections research (23 papers), Influenza Virus Research Studies (22 papers) and Virology and Viral Diseases (7 papers). Kathleen Coelingh is often cited by papers focused on Respiratory viral infections research (23 papers), Influenza Virus Research Studies (22 papers) and Virology and Viral Diseases (7 papers). Kathleen Coelingh collaborates with scholars based in United States, France and Norway. Kathleen Coelingh's co-authors include Brian R. Murphy, Christopher S. Ambrose, Catherine J. Luke, Jennifer Woo, Robert B. Belshe, Xionghua Wu, Hong Jin, William J. Britt, Shengqiang Li and Aurelia A. Haller and has published in prestigious journals such as Journal of Virology, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Kathleen Coelingh

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Coelingh United States 22 1.1k 504 282 148 122 34 1.3k
Thomas A. Janczewski United States 12 863 0.8× 370 0.7× 197 0.7× 261 1.8× 164 1.3× 13 1.1k
Celia Santos United States 18 1.1k 1.0× 476 0.9× 444 1.6× 373 2.5× 165 1.4× 27 1.3k
M H Snyder United States 16 861 0.8× 326 0.6× 167 0.6× 174 1.2× 139 1.1× 16 921
Kutubuddin Mahmood United States 19 1.3k 1.1× 476 0.9× 817 2.9× 172 1.2× 246 2.0× 26 1.7k
Ken Lemon United Kingdom 18 601 0.5× 337 0.7× 142 0.5× 87 0.6× 99 0.8× 29 822
Diane Major United Kingdom 24 1.3k 1.1× 497 1.0× 408 1.4× 278 1.9× 328 2.7× 42 1.5k
E L Tierney United States 26 1.8k 1.6× 704 1.4× 587 2.1× 173 1.2× 291 2.4× 37 2.2k
Emileigh Johnson United States 13 1.1k 1.0× 355 0.7× 255 0.9× 117 0.8× 161 1.3× 21 1.2k
Angela Choi United States 14 711 0.6× 304 0.6× 409 1.5× 76 0.5× 174 1.4× 23 1.0k
Kathleen R. Lottenbach United States 13 598 0.5× 268 0.5× 325 1.2× 44 0.3× 145 1.2× 17 905

Countries citing papers authored by Kathleen Coelingh

Since Specialization
Citations

This map shows the geographic impact of Kathleen Coelingh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Coelingh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Coelingh more than expected).

Fields of papers citing papers by Kathleen Coelingh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Coelingh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Coelingh. The network helps show where Kathleen Coelingh may publish in the future.

Co-authorship network of co-authors of Kathleen Coelingh

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Coelingh. A scholar is included among the top collaborators of Kathleen Coelingh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Coelingh. Kathleen Coelingh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caspard, Hervé, Kathleen Coelingh, Raburn M. Mallory, & Christopher S. Ambrose. (2016). Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. Vaccine. 34(42). 5066–5072. 33 indexed citations
2.
Coelingh, Kathleen, et al.. (2015). Efficacy and effectiveness of live attenuated influenza vaccine in school-age children. Expert Review of Vaccines. 14(10). 1331–1346. 21 indexed citations
3.
Coelingh, Kathleen, Catherine J. Luke, Hong Jin, & Kawsar R. Talaat. (2014). Development of live attenuated influenza vaccines against pandemic influenza strains. Expert Review of Vaccines. 13(7). 855–871. 38 indexed citations
4.
Woo, Jennifer, et al.. (2011). Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference. Expert Review of Vaccines. 10(8). 1131–1141. 51 indexed citations
5.
Belshe, Robert B., Kathleen Coelingh, Christopher S. Ambrose, Jennifer Woo, & Xionghua Wu. (2009). Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine. 28(9). 2149–2156. 122 indexed citations
6.
Karron, Ruth A., Kawsar R. Talaat, Catherine J. Luke, et al.. (2009). Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine. 27(36). 4953–4960. 95 indexed citations
7.
Karron, Ruth A., Karen Callahan, Catherine J. Luke, et al.. (2009). A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults. The Journal of Infectious Diseases. 199(5). 711–716. 59 indexed citations
8.
Ambrose, Christopher S., Catherine J. Luke, & Kathleen Coelingh. (2008). Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza. Influenza and Other Respiratory Viruses. 2(6). 193–202. 87 indexed citations
9.
Jin, Hong, Joel R. Leininger, Catherine J. Luke, et al.. (2007). Toxicological evaluation of live attenuated, cold-adapted H5N1 vaccines in ferrets. Vaccine. 25(52). 8664–8672. 23 indexed citations
10.
Buonagurio, Deborah A., Robert E. O’Neill, Haiping Wang, et al.. (2006). Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting. Virology. 347(2). 296–306. 24 indexed citations
11.
Buonagurio, Deborah A., Chin‐Fen Yang, Haiping Wang, et al.. (2005). Genetic stability of live, cold-adapted influenza virus components of the FluMist®/CAIV-T vaccine throughout the manufacturing process. Vaccine. 24(12). 2151–2160. 25 indexed citations
12.
Greenberg, David P., Robert Walker, Keith S. Reisinger, et al.. (2005). A Bovine Parainfluenza Virus Type 3 Vaccine Is Safe and Immunogenic in Early Infancy. The Journal of Infectious Diseases. 191(7). 1116–1122. 38 indexed citations
13.
Murphy, Brian R. & Kathleen Coelingh. (2002). Principles Underlying the Development and Use of Live Attenuated Cold-Adapted Influenza A and B Virus Vaccines. Viral Immunology. 15(2). 295–323. 138 indexed citations
14.
Greenberg, David P., Sylvia H. Yeh, Ram Yogev, et al.. (2001). Antibody Responses to Bovine Parainfluenza Virus Type 3 (PIV3) Vaccination and Human PIV3 Infection in Young Infants. The Journal of Infectious Diseases. 184(7). 909–913. 31 indexed citations
15.
Haller, Aurelia A., et al.. (2000). Expression of the Surface Glycoproteins of Human Parainfluenza Virus Type 3 by Bovine Parainfluenza Virus Type 3, a Novel Attenuated Virus Vaccine Vector. Journal of Virology. 74(24). 11626–11635. 61 indexed citations
16.
Jin, Hong, David K. Clarke, Helen Zhou, et al.. (1998). Recombinant Human Respiratory Syncytial Virus (RSV) from cDNA and Construction of Subgroup A and B Chimeric RSV. Virology. 251(1). 206–214. 86 indexed citations
17.
18.
Sweet, Thersa, H. F. Maassab, Kathleen Coelingh, & M. Louise Herlocher. (1997). Creation of amantadine resistant clones of influenza type A virus using a new transfection procedure. Journal of Virological Methods. 69(1-2). 103–111. 9 indexed citations
19.
Parkin, Neil, et al.. (1996). Temperature sensitive mutants of influenza A virus generated by reverse genetics and clustered charged to alanine mutagenesis. Virus Research. 46(1-2). 31–44. 14 indexed citations
20.
Lebacq‐Verheyden, Anne‐Marie, et al.. (1987). Processing of the human prepro-gastrin releasing peptide hormone (GRP) expressed in swiss 3T3 mouse embryo fibroblasts and in a baculovirus/insect cell system. Regulatory Peptides. 19(1-2). 122–122. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas A. Janczewski Breakdown of academic impact, for papers by Celia Santos Breakdown of academic impact, for papers by M H Snyder Breakdown of academic impact, for papers by Kutubuddin Mahmood Breakdown of academic impact, for papers by Ken Lemon Breakdown of academic impact, for papers by Diane Major Breakdown of academic impact, for papers by E L Tierney Breakdown of academic impact, for papers by Emileigh Johnson Breakdown of academic impact, for papers by Angela Choi Breakdown of academic impact, for papers by Kathleen R. Lottenbach
Rankless by CCL
2026